A trial of Biogen’s spinal muscular atrophy (SMA) therapy Spinraza (nusinersen) suggests that a higher dose provides benefits ...

Is your company bracing for Milton or working to provide aid in anticipation of the storm? | Pfizer—which opened a global hub ...

Merck & Co. hopes a new positive trial readout can return Keytruda to glory in head and neck cancer. | Merck & Co. hopes a ...

While recent CDC guidance threatens to shrink the market for a new class of immunizations, GSK continues to build the case ...

A new survey commissioned by Big Pharma Roche has found that half of those polled “have either limited or no awareness” of ...

With an estimated 2 million people in the United States taking copycat vers | A compounding industry group has sued the FDA, ...

The Congressional Budget Office found that only one out of the seven policies it reviewed would create notable reductions in ...

Bausch + Lomb has teamed up with American sportscaster Erin Andrews to promote its dry eye disease treatment, launching the ...

Eversana is increasing its reach across the global pharmaceutical industry. | Eversana is increasing its reach across the ...

In the phase 3b BATURA trial, Airsupra—a pressurized metered-dose inhaler containing albuterol and budesonide—significantly ...

Off the scrapheap of discarded drugs and on its way to becoming the most highly anticipated approval of 2024, Bristol Myers ...

With a new patent settlement, generic partners Mylan and Natco have cleared one hurdle to a potential U.S. launch of their ...